The American Association of Immunologists (AAI), the world’s leading professional organization dedicated to advancing the field of immunology, has announced its support for Proposition 38, a historic statewide ballot measure in California that would invest $8.4 billion in cutting-edge immunology research if approved by voters this November.
California is home to some of the nation’s top research institutions, biotechnology companies, and scientific talent. AAI’s support underscores the state’s critical role as a global engine of biomedical innovation—and the importance of sustained investment to maintain that leadership.
“California has long been a U.S. leader in biomedical innovation,” said Loretta Doan, PhD, Chief Executive Officer of AAI. “This initiative represents a forward-looking investment in science, health, and economic growth. By supporting immunology research, California can once again be a shining example to the entire nation as it continues to drive breakthroughs that improve lives and maintains its leadership in developing the next generation of medical advances.”
The immune system plays a central role in nearly all aspects of human health, and advances in immunology have already led to breakthroughs in cancer immunotherapy, vaccines, and treatments for autoimmune diseases—many of which are improving and saving lives today.
AAI joins a growing coalition of scientists, research institutions, patient advocates, and public health leaders supporting the Initiative.
